Astec LifeSciences, a company in the Pesticides & Agrochemicals industry, reported revenue of ₹72 crore and a net loss of ₹37 crore for the September 2026 quarter.
Astec LifeSciences (NSE: ASTEC) closed at ₹541.70 on 20 Nov 2026, down 26.2% over the past year. Its market capitalisation is ₹1,207 crore.
The Company is into manufacturing of agrochemical active ingredients (technical), bulk and formulations, intermediate products and it sells its products in India as well as exports them to approximately 24 countries. Astec also has undertaken a number of custom synthesis projects, for its clients in Europe, Japan and the US. It is present only in business to business sale (B2B).
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.